Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (17)

2024

  1. Cilastatin as a Potential Anti-Inflammatory and Neuroprotective Treatment in the Management of Glaucoma

    International Journal of Molecular Sciences, Vol. 25, Núm. 6, pp. 3115

  2. Diadenosine pentaphosphate regulates dendrite growth and number in cultured hippocampal neurons

    Purinergic Signalling, Vol. 20, Núm. 2, pp. 115-125

2023

  1. TNAP and P2X7R: New Plasma Biomarkers for Alzheimer’s Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 13

2019

  1. The antimicrobials anacardic acid and curcumin are not-competitive inhibitors of Gram-positive bacterial pathogenic glyceraldehyde-3-phosphate dehydrogenase by a mechanism unrelated to human C5A anaphylatoxin binding

    Frontiers in Microbiology, Vol. 10, Núm. FEB

2018

  1. Effects of HIV, antiretroviral therapy and prebiotics on the active fraction of the gut microbiota

    AIDS, Vol. 32, Núm. 10, pp. 1229-1237

2016

  1. Cardiac electrical defects in progeroid mice and Hutchinson-Gilford progeria syndrome patients with nuclear lamina alterations

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, Núm. 46, pp. E7250-E7259

  2. Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals

    EBioMedicine, Vol. 8, pp. 203-216

  3. HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases

    Scientific Reports, Vol. 6

2012

  1. In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 1, pp. 167-169

2010

  1. Comparative activities of TR-700 (Torezolid) against staphylococcal blood isolates collected in spain

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 5, pp. 2212-2215

  2. Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: A flow cytometric study

    Cornea, Vol. 29, Núm. 2, pp. 167-171

  3. Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 12, pp. 5352-5355

  4. Outbreak of Acinetobacter baumannii producing OXA-66 in a Spanish hospital: Epidemiology and study of patient movements

    Microbial Drug Resistance, Vol. 16, Núm. 4, pp. 309-315

  5. Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 12, pp. 5337-5343

  6. The effect of preservative-free HP-Guar on dry eye after phacoemulsification: A flow cytometric study

    Eye, Vol. 24, Núm. 8, pp. 1331-1337

2007

  1. Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques

    European Journal of Pharmacology, Vol. 562, Núm. 1-2, pp. 119-129

2006

  1. Modulación mediante tratamiento con atorvastatina y/o amlodipino del perfil de proteínas liberadas por placas ateroscleróticas humanas

    Clínica e Investigación en Arteriosclerosis, Vol. 18, Núm. 5, pp. 167-175